Cargando…
Targeting fibrosis: mechanisms and clinical trials
Fibrosis is characterized by the excessive extracellular matrix deposition due to dysregulated wound and connective tissue repair response. Multiple organs can develop fibrosis, including the liver, kidney, heart, and lung. Fibrosis such as liver cirrhosis, idiopathic pulmonary fibrosis, and cystic...
Autores principales: | Zhao, Manyu, Wang, Liqun, Wang, Mengzhu, Zhou, Shijie, Lu, Ying, Cui, Huijie, Racanelli, Alexandra C., Zhang, Ling, Ye, Tinghong, Ding, Bisen, Zhang, Ben, Yang, Jinliang, Yao, Yuqin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9247101/ https://www.ncbi.nlm.nih.gov/pubmed/35773269 http://dx.doi.org/10.1038/s41392-022-01070-3 |
Ejemplares similares
-
Nicotinamide Mononucleotide Ameliorates Silica-Induced Lung Injury through the Nrf2-Regulated Glutathione Metabolism Pathway in Mice
por: Wang, Liqun, et al.
Publicado: (2022) -
Liver Fibrosis: Therapeutic Targets and Advances in Drug Therapy
por: Tan, Zui, et al.
Publicado: (2021) -
Nifuroxazide ameliorates pulmonary fibrosis by blocking myofibroblast genesis: a drug repurposing study
por: Gan, Cailing, et al.
Publicado: (2022) -
A novel multikinase inhibitor SKLB‐YTH‐60 ameliorates inflammation and fibrosis in bleomycin‐induced lung fibrosis mouse models
por: Liu, Hongyao, et al.
Publicado: (2021) -
Blueberry Juice Attenuates Pulmonary Fibrosis via Blocking the TGF-β1/Smad Signaling Pathway
por: Li, Yali, et al.
Publicado: (2022)